Boryung Pharm & Lilly sign marketing and partnership agreements of Prozac and Strattera
On the 15th, Boryung Pharm(CEO Tae-Hong Choi) and Lilly Korea(CEO Paul Henry Huibers) signed a marketing and partnership agreement of the antidepressant Prozac(generic name: fluoxetine) and the attention-deficit/hyperactivity disorder(ADHD) treatment Strattera(generic name: atomoxetine).
Prozac,...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
